Sommadossi Jean-Pierre has filed 22 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 300000 shares of Atea Pharmaceuticals, Inc. ($AVIR) on February 03, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.38% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 99517 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.13% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 173466 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.22% |
| Feb. 3, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 300000 | $1.24 | 6,633,855.0000 | 78,126,796 | 4.74% | 0.38% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | F | Common Stock | 106093 | $4.24 | 6,333,855.0000 | 78,126,796 | 1.65% | 0.14% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 272983 | $0.00 | 6,439,948.0000 | 78,126,796 | 4.43% | 0.35% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 173467 | $0.00 | 6,156,049.0000 | 0 | 2.90% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Common Stock | 99517 | $0.00 | 6,255,566.0000 | 0 | 1.62% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | F | Common Stock | 88601 | $3.06 | 6,166,965.0000 | 0 | 1.42% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 173467 | $0.00 | 173,466.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Restricted Stock Units | 99518 | $0.00 | 99,518.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 17, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 33941 | $4.05 | 6,006,610.0000 | 0 | 0.56% | 0.00% |
| Sept. 18, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 22187 | $4.03 | 5,984,423.0000 | 0 | 0.37% | 0.00% |
| Sept. 19, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 1841 | $4.00 | 5,982,582.0000 | 0 | 0.03% | 0.00% |
| June 5, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 1006 | $4.00 | 6,040,551.0000 | 0 | 0.02% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 173467 | $0.00 | 6,098,467.0000 | 0 | 2.93% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Stock Option (Right to Buy) | 448000 | $0.00 | 448,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 56910 | $3.85 | 6,041,557.0000 | 0 | 0.93% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 173467 | $0.00 | 346,933.0000 | 0 | 33.33% | 0.00% |
| Jan. 31, 2023 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Stock Option (Right to Buy) | 728600 | $0.00 | 728,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Atea Pharmaceuticals, Inc. | $AVIR | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Restricted Stock Units | 520400 | $0.00 | 520,400.0000 | 0 | 9999.99% | 0.00% |